Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020, 164(3):267-272 | DOI: 10.5507/bp.2019.019

Associations between CYP2J2 (-76G>T) rs890293 polymorphism and age-related macular degeneration

Rasa Liutkevicienea,b, Alvita Vilkeviciutea, Roman Botovc, Olga Botovab, Dovile Buteikieneb, Loresa Kriauciunienea,b
a Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eivenių 2, Kaunas, Lithuania, LT-50009
b Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Eivenių 2, Kaunas, Lithuania, LT-50009
c Medical Academy, Lithuanian University of Health Sciences, Eivenių 2, Kaunas, Lithuania, LT-50009

Backgroung. Age-related macular degeneration (AMD) is a disease of the macula, which significantly affects the eyesight and leads to irreversible central vision loss. The etiopathogenesis of AMD is still not absolutely clear. It is thought that age-related macular degeneration has a multifactorial etiology, the development of which may be caused by interrelation of environmental with innate factors, while genetic factors also have an impact. Macular degenerative changes occur due to the formation of drusen, about 40% of which is lipids. As the CYP2J2 gene is involved in the metabolism of lipids, it was selected for investigation in this study. Purpose. To determine the relation between early stage and exudative AMD and CYP2J2 (-76G>T) gene rs890293 polymorphism in a Lithuanian population.

Methods: The study enrolled 204 patients with early AMD, 197 patients with exudative AMD and 198 healthy controls. Samples of DNA from peripheral white blood cells were purified using commercial kits. The genotyping was carried out using a real-time PCR method.

Results: The CYP2J2 (-76G>T) rs890293 TT genotype in patients with early AMD was statistically significantly less frequent than in the control group: 0% vs. 2.5% (P=0.028). There were no significant differences in rs890293 gene polymorphisms between the exudative AMD and control groups. Also, the CYP2J2 (-76G>T) rs890293 TT genotype was statistically significantly less frequent in older early AMD patients (≥65 years) compared to control group persons (≥65 years): 0% vs. 5.4% (P=0.03).

Conclusion: The CYP2J2 (-76G>T) TT genotype may be associated with reduced manifestation of early stage AMD; therefore, a larger sample size is required for further analysis.

Keywords: age-related macular degeneration, rs890293, gene polymorphisms

Received: December 26, 2018; Accepted: April 23, 2019; Prepublished online: May 23, 2019; Published: September 17, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Liutkeviciene, R., Vilkeviciute, A., Botov, R., Botova, O., Buteikiene, D., & Kriauciuniene, L. (2020). Associations between CYP2J2 (-76G>T) rs890293 polymorphism and age-related macular degeneration. Biomedical papers, 164(3), 267-272. doi: 10.5507/bp.2019.019
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR; Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. Ophthalmo 2013;120(4):844-51. Go to original source... Go to PubMed...
    2. Cheng J, Edin ML, Hoopes SL, Li H, Bradbury JA, Graves JP, DeGraff LM, Lih FB, Garcia V, Shaik FSB, Tomer KB, Flake GP, Falck JR, Lee CR, Poloyac SM, Schwartzman ML, Zeldin DC. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2. FASEB J 2014;28(7):2915-31. Go to original source... Go to PubMed...
    3. Liutkeviciene R, Lesauskaite V, Asmoniene V, Zaliūniene D, Jasinskas V. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 2010;46(2):89-94. Go to original source... Go to PubMed...
    4. Sharma K, Sharma NK, Anand A. Why AMD is a disease of ageing and not of development: mechanisms and insights. Front Aging Neurosci 2014;10:6-15. Go to original source... Go to PubMed...
    5. Knickelbein JE, Chan CC, Sen HN, Ferris FL, Nussenblatt RB. Inflammatory Mechanisms of Age-related Macular Degeneration. Int Ophthalmol Clin 2015;55(3):63-78. Go to original source... Go to PubMed...
    6. Èolak E, Ignjatovic S, Radosavljeviè A, ®oriè L. The association of enzymatic and non enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration. J Clin Biochem Nutr 2017;60(2):100-7. Go to original source... Go to PubMed...
    7. Gilroy DW, Edin ML, De Maeyer RP, Bystrom J, Newson J, Lih FB, Stables M, Zeldin DC, Bishop-Bailey D. CYP450-derived oxylipins mediate inflammatory resolution. Proc Natl Acad Sci U S A 2016;113(23):E3240-9. Go to original source... Go to PubMed...
    8. Hardwick, James P. Cytochrome P450 function and pharmacological roles in inflammation and cancer. Adv Pharmacol 2015;74:xv-xxxi. doi: 10.1016/S1054-3589(15)00047-2. Go to original source... Go to PubMed...
    9. Liutkeviciene R, Lesauskaite V, Sinkunaite-Marsalkiene G, Zaliuniene D, Zaliaduonyte-Peksiene D, Mizariene V, Gustiene O, Jasinskas V, Jariene G, Tamosiunas A. The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration. Ophthalmic Genet 2015;36(2):149-5. Go to original source... Go to PubMed...
    10. Liutkeviciene R, Lesauskaite V, Asmoniene V, Zaliūniene D, Jasinskas V. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 2010;46(2):89-94. Go to original source... Go to PubMed...
    11. Sakiene R, Vilkeviciute A, Kriauciuniene L, Balciuniene VJ, Buteikiene D, Miniauskiene G, Liutkeviciene R. CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration. Adv Med 2016;2016:3917916. Go to original source... Go to PubMed...
    12. Geng S, Wang Y, Sun Y, Li J, Yin H, Zeng Z, Yang X, Zhang Y, Wang Y. Gene- gene interaction between CYP2J2 and PPAR -γ gene on late-onset Alzheimer's disease in the eastern Chinese Han population. Behav Brain Res 2017;322;362-7. Go to original source... Go to PubMed...
    13. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001;132:668-81.
    14. Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Börgel J, Mügge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 2004;110;2132-6. Go to original source... Go to PubMed...
    15. King LM, Ma J, Srettabunjong S, Graves J, Bradbury JA, Li L, Spiecker M, Liao JK, Mohrenweiser H, Zeldin DC. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol. Pharmacol 2002;61:840-52. Go to original source... Go to PubMed...
    16. Stasiukonyte N, Liutkeviciene R, Vilkeviciute A, Banevicius M, Kriauciuniene L. Associations between Rs4244285 and Rs762551 gene polymorphisms and age-related macular degeneration. Ophthalmic Genet 2017;17:1-8. Go to original source... Go to PubMed...
    17. Sakiene R, Vilkeviciute A, Kriauciuniene L, Balciuniene VJ, Buteikiene D, Miniauskiene G, Liutkeviciene R. CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration. Adv Med 2016;2016:3917916. Go to original source... Go to PubMed...
    18. Yan H, Kong Y, He B, Huang M, Li J, Zheng J, Liang L, Bi J, Zhao S, Shi L. CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population. Neuroscience Letters 2015;593:56-60. Go to original source... Go to PubMed...
    19. Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC. CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study. Pharmacogenet. Genomics 2007;17:349-58. Go to original source...
    20. Liu PY, Li YH, Chao TH, Wu HL, Lin LJ, Tsai LM, Chen JH. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction. Atherosclerosis 2007;195:199-206. Go to original source... Go to PubMed...
    21. Curcio CA, Johnson M, Huang JD, Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 2010;51(3):451-67. Go to original source... Go to PubMed...
    22. Ebrahimi KB, Handa JT. Lipids, lipoproteins, and age-related macular degeneration. J Lipids 2011;2011:802059. Go to original source... Go to PubMed...
    23. Butt AL, Lee ET, Klein R, Russell D, Ogola G, Warn A, Kingsley RM, Yeh J. Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study. Ophthalmology 2011;118(7):1380-5. Go to original source... Go to PubMed...
    24. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, van Duijn CM, Stricker BH, De Jong PT. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 2004;137(4):750-2. Go to original source... Go to PubMed...
    25. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, Pankow JS, Klein BE. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 2010;128:750-8. Go to original source... Go to PubMed...
    26. Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143-50. Go to original source... Go to PubMed...
    27. Cackett P, Wong TY, Aung T, Saw SM, Tay WT, Vithana EN, Wong D, Tay WT, Tai ES, Aung T, Wong TY. Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. Am J Ophthalmol 2008;146(6):960-7. Go to original source... Go to PubMed...
    28. Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280-7. Go to original source... Go to PubMed...
    29. Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology 2010;117(10):1989-95. Go to original source... Go to PubMed...
    30. Nowak M, Swietochowska E, Marek B, Szapska B, Wielkoszynski T, Kos-Kudla B, Karpe J, Kajdaniuk D, Sieminska L, Glogowska-Szelag J, Nowak K. Changes in lipid metabolism in women with age-related macular degeneration. Clin Exp Med 2005;4(4):183-7. Go to original source... Go to PubMed...
    31. Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE, Chan W, Knox A, Cartmill B, Chakravarthy U. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008;115(6):1046-1052.e2 Go to original source... Go to PubMed...
    32. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 2002;109(6):1092-7. Go to original source... Go to PubMed...
    33. Ulas F, Balbaba M, Ozmen S, Celebi S, Dogan U. Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration. Int Ophthalmol 2013;33(5):485-91. Go to original source... Go to PubMed...
    34. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010;13(12):10:31. Go to original source... Go to PubMed...
    35. Cougnard-Grégoire A, Delyfer MN, Korobelnik JF, Rougier MB, Goff M, Dartigues JF, Barberger-Gateau P, Delcourt C. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the alienor study. PLoS One 2014;9(3):e90973. Go to original source... Go to PubMed...
    36. Yan H, Kong Y, He B, Huang M, Li J, Zheng J, Liang L, Bi J, Zhao S, Shi L. CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population. Neuroscience Letters 2015;593:56-60. Go to original source... Go to PubMed...
    37. Zhu Q1, Fu Z, Ma Y, Yang H, Huang D, Xie X, Liu F, Zheng Y, Cha E. A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China. Clin Biochem 2013;46(12):1047-54.
    38. Ali A, Wassim N, Dowaidar M, Yaseen A. Association of eNOS (E298D) and CYP2J2 (-50G/T) gene polymorphisms with hypertension among Egyptian cases. J Basic Appl Zool 2013;66(4):234-41. Go to original source...
    39. Xu M, Ju W, Hao H,. Wang G, Li P. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metabol Rev 2013;45:311-52. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content